Crohn’s Disease Study Shows Genetic Component
A UK study has shown that there may be a genetic variant carried by 40% of Crohn’s disease sufferers that explains why some patients develop antibodies against some of the…
A UK study has shown that there may be a genetic variant carried by 40% of Crohn’s disease sufferers that explains why some patients develop antibodies against some of the…
As originally reported in Nottinghamshire Live, oculocutaneous albinism is a rare inherited disease thats recognizable to some; many know it for causing pale features, white hair, and light eyes. It…
Rest In Peace, Senator Kay Hagan, who unexpectedly died Monday at the age of 66. It has been widely reported that Senator Hagan was diagnosed with encephalitis in 2016, which…
November 1st is Acromegaly Awareness Day! Let's do our part by getting a deep dive into acromegaly and the resources available for the acromegaly community! What is Acromegaly? Acromegaly is…
According to a story from Medscape, the treatment of melanoma, particularly more advanced, metastatic melanoma, has improved significantly over the last couple of decades. Dr. Philip Friedlander says that in…
According to a story from Juvenile Arthritis News, a recent study from China has found that early treatment with infliximab (marketed as Remicade) can reduce inflammation and indicators of active…
According to a story from BioSpace, the genetic medicines company Homology Medicines, Inc., has recently released preclinical data supporting the development of two experimental gene therapies. One, called HMI-202, is…
Results of a study reported in PLOS ONE that was conducted by a team of scientists indicate that the experimental drug mavoglurant improves responsiveness and eye gaze for patients with…
Actus Therapeutics, a privately held portfolio company of AskBio, has recently announced through PRWeb, the initiation of patient dosing in a clinical trial testing its investigational gene therapy ACTUS-101. About Pompe…
As originally reported in South Africa Latest News, Healx Ltd. has raised $56 million dollars to fund their development of treatment options for rare diseases using artificial intelligence. The British…